Catalyst News and Research

RSS

Elephant genes could offer new clues to preventing cancer development

Scientists modeling the cancer-suppressing p53 gene identify how the 20 different molecules unique to elephants get activated for increased sensitivity and response against carcinogenic conditions - with implications for cancer treatments in humans.

19 Jul 2022

Grant funds research that investigates relationships between certain fungi and specific cancers

Dr. Iliyan D. Iliev, an associate professor of immunology and microbiology in the Division of Gastroenterology and Hepatology and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine, has been awarded a five-year, $1.25 million CRI Lloyd J. Old STAR (Scientists Taking Risks) Program grant from Cancer Research Institute (CRI).

19 Jul 2022

Infection in early life can increase a baby's sensitivity to pain

Researchers from Oxford's Department of Pediatrics have discovered that infection can increase a baby's sensitivity to pain, which may last longer than the infection.

12 Jul 2022

University of Oxford begins recruiting for Phase I trial of new TB vaccine

The University of Oxford has begun recruiting for a Phase I trial with a tuberculosis vaccine in human volunteers at Oxford to develop a new way to test the efficacy of future TB vaccines - with the first volunteers being challenged today (Wednesday).

12 Jul 2022

Seeking to kick-start Biden’s agenda, Schumer unveils a bill for Medicare drug price negotiations

Democratic senators on Wednesday took a formal step toward reviving President Joe Biden's economic agenda, starting with a measure to let Medicare negotiate prices with drugmakers and to curb rising drug costs more broadly.

7 Jul 2022

How to get rid of medical debt — or avoid it in the first place

Lori Mangum was 32 when apple-size tumors sprouted on her head. Now — six years and 10 surgeries later — the skin cancer is gone. But her pain lives on, in the form of medical debt.

1 Jul 2022

HIV accelerates epigenetic aging soon after initial HIV infection

HIV has an "early and substantial" impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers and colleagues.

1 Jul 2022

Patients to benefit from a super-charged clinical research system

Patients across the UK will benefit from a super-charged clinical research system, backed by £175 million of dedicated investment, which will save lives across the country.

30 Jun 2022

Study identifies a new mechanism that explains how immune cells learn to discern friend from foe

The human immune system is a nearly perfect defense mechanism. It protects the body from disease-causing bacteria, viruses, and other pathogens. It detects nascent tumors and eradicates them. It cleans up cellular debris at the site of injury or infection.

28 Jun 2022

Scientists discover mechanism behind zoonotic transfer of SARS-CoV-2 virus

The original SARS-CoV-2 viral strain that emerged in early 2020 was able to latch on to sugars known as sialic acids, found on the surface of human cells, an ability that later strains did not retain.

24 Jun 2022

Researchers improve the ability of a protein to repair oxidative DNA damage

Researchers at Karolinska Institutet and SciLifeLab in Sweden describe in a study published in Science how they have improved the ability of a protein to repair oxidative DNA damage and created a new protein function.

23 Jun 2022

Study provides better understanding of the brain pathways that control nausea

Nausea is a bit of a catchall sensation for the human body: the unpleasant sick feeling can hit us as a result of everything from pregnancy or a migraine to eating spoiled food or undergoing chemotherapy.

22 Jun 2022

Medical bills can shatter lives. North Carolina may act to ‘de-weaponize’ that debt.

When Erin Williams-Reavis faced a $3,500 surgery bill, the hospital offered to let her pay in $300 monthly installments.

21 Jun 2022

Study shines new light on the role of key Parkinson’s disease protein

One of the hallmarks of Parkinson's disease (PD) is the accumulation in the brain of a protein known as alpha-synuclein. For more than two decades, alpha-synuclein has been a focal point of attention for researchers, clinicians and drug makers interested in PD.

9 Jun 2022

University screening programs gave scientists early insights about omicron’s spread

Omicron was first reported in South Africa on Nov. 24, 2021, and within mere days it was already making the rounds in the United States, spiking SARS-CoV-2 case numbers as it infiltrated every school, restaurant, and family gathering. But when exactly did omicron unseat the delta variant to become dominant? And how quickly did it actually take over?

9 Jun 2022

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

The American College of Chest Physicians (CHEST) and Three Lakes Foundation are announcing a steering committee of experts in the fields of pulmonary medicine and primary care medicine to lead an initiative called Bridging Specialties™: Timely Diagnosis for ILD Patients.

9 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalization and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

7 Jun 2022

Truncated tau protein may be a means for better diagnosis and treatment of Alzheimer's disease

In a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied form of the tau protein associated with neurodegeneration may be a means for better diagnosis and treatment of the disease.

2 Jun 2022

Researchers develop oil-based gels as drug delivery systems for children in resource-limited countries

Administering medications to children poses unique challenges, especially in resource-limited countries with high infant and child mortality rates.

27 May 2022

Catalyst News and Research

Elephant genes could offer new clues to preventing cancer development

Grant funds research that investigates relationships between certain fungi and specific cancers

Infection in early life can increase a baby's sensitivity to pain

University of Oxford begins recruiting for Phase I trial of new TB vaccine

Seeking to kick-start Biden’s agenda, Schumer unveils a bill for Medicare drug price negotiations

How to get rid of medical debt — or avoid it in the first place

HIV accelerates epigenetic aging soon after initial HIV infection

Patients to benefit from a super-charged clinical research system

Study identifies a new mechanism that explains how immune cells learn to discern friend from foe

Scientists discover mechanism behind zoonotic transfer of SARS-CoV-2 virus

Researchers improve the ability of a protein to repair oxidative DNA damage

Study provides better understanding of the brain pathways that control nausea

Medical bills can shatter lives. North Carolina may act to ‘de-weaponize’ that debt.

Study shines new light on the role of key Parkinson’s disease protein

University screening programs gave scientists early insights about omicron’s spread

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

Truncated tau protein may be a means for better diagnosis and treatment of Alzheimer's disease

Researchers develop oil-based gels as drug delivery systems for children in resource-limited countries

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News